Position in SGMT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$67,219
-$8,941 QoQ
Shares Held
12,865
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jasper Ridge Partners, L.P. holds $10,103,455 across 14 Biotechnology names. SGMT ranks #12 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
42,455 | $2,087,087 | |
| 2 | ACLX |
Arcellx, Inc.
|
13,947 | $1,601,394 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
95,711 | $1,483,520 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
14,368 | $1,397,288 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
13,845 | $1,204,099 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,248 | $577,190 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
9,539 | $453,770 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
10,154 | $408,495 |
All Filings in SGMT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,219 | 12,865 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $76,160 | 12,865 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $130,340 | 19,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $144,780 | 19,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,940 | 19,000 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||